Evidence map›Paper›PMID 28743607›Full record

ArticleJournal of pharmaceutical sciences2017

Comparative Characterization of Crofelemer Samples Using Data Mining and Machine Learning Approaches With Analytical Stability Data Sets.

Maulik K Nariya, Jae Hyun Kim, Jian Xiong, Peter A Kleindl, Asha Hewarathna, Adam C Fisher, Sangeeta B Joshi, Christian Schöneich, M Laird Forrest, C Russell Middaugh and 2 more

Abstract readComparative Study
In one paragraph

Article in Journal of pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maulik K NariyaDepartment of Physics and Astronomy, University of Kansas, Lawrence, Kansas 66045.
Jae Hyun KimDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045.
Jian XiongDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045; Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66045.
Peter A KleindlDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045.
Asha HewarathnaDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045.
Adam C FisherCenter for Drug Evaluation and Research, Office of Pharmaceutical Quality, U.S. Food and Drug Administration, Silver Spring, Maryland 20993.
Sangeeta B JoshiDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045; Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66045.
Christian SchöneichDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045.
M Laird ForrestDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045.
C Russell MiddaughDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045; Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66045.
David B VolkinDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66045; Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas 66045.
Eric J DeedsDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045; Center for Computational Biology, University of Kansas, Lawrence, Kansas 66045; Santa Fe Institute, Santa Fe, New Mexico 87501. Electronic address: deeds@ku.edu.

Funding

Biomaterials for treatment of head and neck cancerR01CA173292 · NCI · UNIVERSITY OF KANSAS LAWRENCE · PI FORREST, MARCUS LAIRD · 2013 to 2017
$1.4M
Development of an Integrated Mathematical Model for Comparative Characterization of Complex MoleculeU01FD005285 · FDA · UNIVERSITY OF KANSAS LAWRENCE · PI FORREST, MARCUS LAIRD, MIDDAUGH, CHARLES RUSSELL · 2014 to 2016
$1.0M
FDA HHS U01 FD005285NCI NIH HHS R01 CA173292
6 · The paper itself

Abstract

There is growing interest in generating physicochemical and biological analytical data sets to compare complex mixture drugs, for example, products from different manufacturers. In this work, we compare various crofelemer samples prepared from a single lot by filtration with varying molecular weight cutoffs combined with incubation for different times at different temperatures. The 2 preceding articles describe experimental data sets generated from analytical characterization of fractionated and degraded crofelemer samples. In this work, we use data mining techniques such as principal component analysis and mutual information scores to help visualize the data and determine discriminatory regions within these large data sets. The mutual information score identifies chemical signatures that differentiate crofelemer samples. These signatures, in many cases, would likely be missed by traditional data analysis tools. We also found that supervised learning classifiers robustly discriminate samples with around 99% classification accuracy, indicating that mathematical models of these physicochemical data sets are capable of identifying even subtle differences in crofelemer samples. Data mining and machine learning techniques can thus identify fingerprint-type attributes of complex mixture drugs that may be used for comparative characterization of products.

Indexed as

AntidiarrhealsCell LineChloride ChannelsCircular DichroismData MiningDrug StabilityHumansMachine LearningPrincipal Component AnalysisProanthocyanidinsSpectrophotometry, UltravioletSpectroscopy, Fourier Transform InfraredAntidiarrhealsChloride ChannelscrofelemerProanthocyanidinscomparative characterizationcrofelemerdata miningsupervised learning

Identifiers

PMID28743607
PMCPMC6588356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.